The $21.6 million grant will fund the development of a tuberculosis assay, which will be designed for use in both resource-constrained and well-resourced settings. It will also support the company’s ...

Alere to Develop Simple, Affordable Point-of-Care Nucleic Acid Test for Tuberculosis & Expand Manufacturing for POC HIV Viral Load Platform WALTHAM, Mass., March 1, 2013 /PRNewswire/ -- Alere Inc.

Tuberculosis is a serious lung infection caused by germs that spread via the air. Despite advances in medical therapy to cure tuberculosis, prevention remains the best strategy. Dr. Shweta Bansal, ...

A simple blood test that accurately diagnoses active tuberculosis could save hundreds of thousands of lives each year, experts said today. The test makes it easier and cheaper to control the disease, ...

Each year, 9.6 million people become infected with tuberculosis; 1.5 million of them die. The rest silently carry the bacterium in a latent state, with the constant threat that it could become active ...

ATS 2016, SAN FRANCISCO - A streamlined approach to tuberculosis (TB) diagnosis requiring a single sputum sample and providing rapid, accurate results to patients proved feasible in rural Uganda, ...

WALTHAM, Mass., March 1, 2013 /PRNewswire/ -- Alere Inc. announced today that it has been awarded a grant of up to $21.6 million and debt financing of up to $20.6 million from the Bill & Melinda Gates ...